Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers (Q43842059)

27 November 2017

Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers (English)

1 reference

27 November 2017

1 reference

Daniel Umbricht

1

1 reference

27 November 2017

Rene Koller

series ordinal

2

1 reference

27 November 2017

Franz X Vollenweider

series ordinal

3

1 reference

27 November 2017

Liselotte Schmid

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

27 November 2017

Biological Psychiatry

1 reference

27 November 2017

51

1 reference

27 November 2017

5

1 reference

27 November 2017

400-406

1 reference

Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Brain potential evidence for an auditory sensory memory deficit in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Effects of signal probability on sensory evoked potentials in cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

The standardized psychometric assessment of altered states of consciousness (ASCs) in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Detection of stimulus deviance within primate primary auditory cortex: intracortical mechanisms of mismatch negativity (MMN) generation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Differentiation of negative event-related potentials in an auditory discrimination task

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Glutamate receptor dysfunction and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Dissociation of the mismatch negativity and processing negativity attentional waveforms with nitrous oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

The mismatch negativity of event-related potentials as a probe of transient auditory memory: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

N-methyl-D-aspartate enhancement of phasic responses in primate neocortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Effects of clozapine on auditory event-related potentials in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

10.1016/S0006-3223(01)01242-2

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference